Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

JMP Securities analyst Nicholas Jones CFA maintained a Buy rating on Booking Holdings (BKNG – Research Report) today and set a price target of ...

Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chairman and Chief Executive Officer, Michael Reed, ...

Citizens JMP last night downgraded Fiverr (FVRR) to Market Perform from Outperform without a price target The company ...

LegalZoom.com, Inc. (Nasdaq: LZ), a leading online platform for legal services, today announced that Jeff Stibel, Chairman and Chief Executive Officer, and Noel Watson, Chief Operating Officer and ...

As JFK Terminal 6 prepares for its anticipated opening in 2026, the terminal, has announced the release of Requests for ...

JMP Securities maintained its optimistic stance on AtriCure Inc. (NASDAQ:ATRC), reiterating a Market Outperform rating and a $60.00 price target. The firm's analysts highlighted their anticipation for ...

The broker raised its Coinbase price target to $475 from $400 while maintaining its market outperform rating on the stock.

Chardan Capital raised their FY2025 earnings estimates for shares of Solid Biosciences in a research report issued to clients and investors on Wednesday, February 19th. Chardan Capital analyst Y.

We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where CyberArk Software Ltd. (NASDAQ:CYBR) stands against the other AI stocks.

JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...

We recently compiled a list of the 8 AI Stocks on Investors’ Radar. In this article, we are going to take a look at where Axon Enterprise, Inc. (NASDAQ:AXON) stands against the other AI stocks. As the ...